Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer
Authors
Keywords
Toxicity, Pharmacogenetics, Irinotecan, Oxaliplatin, Colorectal cancer
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 71, Issue 6, Pages 1463-1472
Publisher
Springer Nature
Online
2013-03-30
DOI
10.1007/s00280-013-2145-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- UGT1A1*28 and Other UGT1A Polymorphisms as Determinants of Irinotecan Toxicity
- (2014) P. Biason et al. JOURNAL OF CHEMOTHERAPY
- Impact of glutathione-S-transferase gene polymorphisms on enzyme activity, lung function and bronchial asthma susceptibility in Egyptian children
- (2012) Rehab A. Karam et al. GENE
- Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients
- (2012) Lucía Cortejoso et al. PHARMACOGENOMICS
- A genotype-directed phase I–IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer
- (2011) E Marcuello et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients
- (2011) Katerina Shulman et al. CANCER
- Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes
- (2011) M. Inada et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Thymidylate Synthase Genotype-Directed Neoadjuvant Chemoradiation for Patients With Rectal Adenocarcinoma
- (2011) Benjamin R. Tan et al. JOURNAL OF CLINICAL ONCOLOGY
- The determination of relationship between “excision repair cross-complementing group 1” (ERCC1) gene T19007C and C8092A single nucleotide polymorphisms and clinicopathological parameters in non-small cell lung cancer
- (2011) Esin Koç et al. MOLECULAR BIOLOGY REPORTS
- Poly(ADP-ribose) polymerase and XPF–ERCC1 participate in distinct pathways for the repair of topoisomerase I-induced DNA damage in mammalian cells
- (2011) Yong-Wei Zhang et al. NUCLEIC ACIDS RESEARCH
- UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy
- (2010) E Martinez-Balibrea et al. BRITISH JOURNAL OF CANCER
- Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer
- (2010) Wei Chua et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients
- (2010) M. Taheri et al. GENETICS AND MOLECULAR RESEARCH
- Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741
- (2010) Howard L. McLeod et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacogenetic Assessment of Toxicity and Outcome in Patients With Metastatic Colorectal Cancer Treated With LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05
- (2010) Valérie Boige et al. JOURNAL OF CLINICAL ONCOLOGY
- ABCB1gene polymorphisms are associated with adverse reactions in fluoropyrimidine-treated colorectal cancer patients
- (2010) Eva Gonzalez-Haba et al. PHARMACOGENOMICS
- Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin
- (2010) Michael A Gordon et al. PHARMACOGENOMICS
- Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer
- (2010) B Glimelius et al. PHARMACOGENOMICS JOURNAL
- Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
- (2009) W Chua et al. BRITISH JOURNAL OF CANCER
- Influence ofGSTP1I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma
- (2009) Yen-Chung Chen et al. CANCER SCIENCE
- ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer
- (2009) Mariusz Panczyk et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens
- (2009) Mehmet Artac et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer
- (2009) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Colorectal Cancer: The FOCUS Trial
- (2009) Michael S. Braun et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
- (2009) Eray Goekkurt et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive Role of the UGT1A1, UGT1A7, and UGT1A9 Genetic Variants and Their Haplotypes on the Outcome of Metastatic Colorectal Cancer Patients Treated With Fluorouracil, Leucovorin, and Irinotecan
- (2009) Erika Cecchin et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics
- (2009) Federico Innocenti et al. JOURNAL OF CLINICAL ONCOLOGY
- UGT1A1*28genotype predicts gastrointestinal toxicity in patients treated with intermediate-dose irinotecan
- (2009) Roberta Ferraldeschi et al. PHARMACOGENOMICS
- Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients
- (2008) E Rouits et al. BRITISH JOURNAL OF CANCER
- UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study
- (2008) D M Kweekel et al. BRITISH JOURNAL OF CANCER
- UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma
- (2008) Chun-Yu Liu et al. CANCER
- Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741
- (2008) Hanna K. Sanoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients
- (2008) Radka Vaclavikova et al. Pharmacogenetics and Genomics
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now